Safety data for stevia extracts is ‘robust’: Cargill/Coke-funded study

By Stephen DANIELLS

- Last updated on GMT

Safety data for stevia extracts is ‘robust’: Cargill/Coke-funded study

Related tags: Steviol glycosides, Stevia

All stevia glycosides are safe with respect to their genotoxic/carcinogenic potential, says a new review that seeks to silence doubts once and for all about the ingredient’s potential in food and beverage products.

Stevia has GRAS (Generally Recognized As Safe) status in the US, and steviol glycosides were approved for EU-use in 31 food categories, including high-fiber breakfast cereals.

Despite a wealth of safety data in its favor, two recent publications (Brahmachari et al., 2011, Arch. Pharm​.344, 5–19, Tandel, 2011, J. Pharmacol. Pharmacother.​ 2, 236–243) have raised questions about the safety of the ingredient.

The new paper, published in Food and Chemical Toxicology​and funded by Cargill Inc. and The Coca-Cola Company, lays to rest any such concerns, and concludes that: “The recent suggestions that steviol glycosides present a mutagenic – and therefore carcinogenic – risk to consumers are not supported by actual test results.

“The database of genotoxicity studies for steviol glycosides and steviol as it currently stands, combined with a lack of evidence for neoplasm development in rat bioassays, is adequate to establish the safety of these food ingredients with respect to their genetic/carcinogenic potential.”

The new paper is authored by Dr. Jonathan Urban and Dr. Michael Carakostas from ToxStrategies, Inc., and David Brusick from the Brusick Consultancy.

Review details

Dr Urban and his co-authors analyzed the genotoxicity studies causing the concern, as well as the overall database of evidence including more recent genotoxicity data.

“The current database of in vitro and in vivo studies for steviol glycosides is robust and does not indicate that either stevioside or rebaudioside A are genotoxic,”​ they said.

“The fact that steviol and stevioside have already shown to be negative in both the [unscheduled DNA synthesis] and the more sensitive comet assay argues that further study of the genotoxicity potential of steviol glycosides using transgenic animals is unwarranted.”

Source: Food and Chemical Toxicology
Volume 51, January 2013, Pages 386-390
“Steviol glycoside safety: Is the genotoxicity database sufficient?”
Authors: J.D. Urban, M.C. Carakostas, D.J. Brusick

Related news

Related products

show more

Food & CPG Packaging Systems: 4 Questions to Ask

Food & CPG Packaging Systems: 4 Questions to Ask

Husky Injection Molding Systems Ltd. | 14-Sep-2021 | Insight Guide

A series of market trends are “changing the game” for packaging and introducing new challenges and opportunities for food and consumer packaged goods (CPG)...

Plant-based proteins revolutionizing convenience

Plant-based proteins revolutionizing convenience

Cargill | 13-Sep-2021 | Technical / White Paper

Sales of plant-based products saw double-digit growth in 2020 – and the marriage of convenience foods with plant proteins is bringing even more momentum...

Our natural ingredients providing umami & kokumi

Our natural ingredients providing umami & kokumi

Lallemand Bio-Ingredients | 07-Sep-2021 | Technical / White Paper

Several Mintel studies highlight consumers’ interest in eating more natural and less-processed diets. This represents an opportunity for brands to remove...

Your Complete Guide to Inventory Forecasting

Your Complete Guide to Inventory Forecasting

Oracle NetSuite | 24-Aug-2021 | Technical / White Paper

Accurate forecasting determines how much product a business needs to fulfill customer orders, and it also ensures that they don't spend too little...

Related suppliers

Follow us

Products

View more

Webinars